Jae Park

Hematology | Oncology

530 E 74th St
New York, NY 10021

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 331 publications

Outpatient Treatment-Related Toxicity After Hospital Discharge Among Patients Receiving Lifileucel for Advanced Melanoma.

Outpatient Treatment-Related Toxicity After Hospital Discharge Among Patients Receiving Lifileucel for Advanced Melanoma.

Journal: JCO oncology practice

Published: August 25, 2026

Proof of Concept of Large Language Models for Opioid Treatment Policy Surveillance: 97% Agreement With Subject Matter Experts.

Proof of Concept of Large Language Models for Opioid Treatment Policy Surveillance: 97% Agreement With Subject Matter Experts.

Journal: Journal of studies on alcohol and drugs

Published: August 22, 2026

Customized Maxillary Expansion in a Child with Unilateral Cleft Lip and Palate and Multiple Anchorage Teeth Loss.

Customized Maxillary Expansion in a Child with Unilateral Cleft Lip and Palate and Multiple Anchorage Teeth Loss.

Journal: The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association

Published: August 06, 2026

Erratum to: "Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/ refractory B-cell acute lymphoblastic leukemia".

Erratum to: "Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/ refractory B-cell acute lymphoblastic leukemia".

Journal: Haematologica

Published: August 01, 2026

Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.

Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.

Journal: Science translational medicine

Published: July 29, 2026

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Journal: Cancer

Published: May 01, 2026

Safety and outcomes of CD19 CAR-T cell therapy in splenectomized patients with B-cell lymphomas.

Safety and outcomes of CD19 CAR-T cell therapy in splenectomized patients with B-cell lymphomas.

Journal: Transplantation and cellular therapy

Published: April 24, 2026

Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus.

Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus.

Journal: Cancer

Published: April 02, 2026

Search for the Decay B^{+}→K^{+}τ^{+}τ^{-} Using Data from the Belle and Belle II Experiments.

Search for the Decay B^{+}→K^{+}τ^{+}τ^{-} Using Data from the Belle and Belle II Experiments.

Journal: Physical review letters

Published: March 27, 2026

Searches for Charged-Lepton-Flavor Violation in χ_{bJ}(1P) Decays.

Searches for Charged-Lepton-Flavor Violation in χ_{bJ}(1P) Decays.

Journal: Physical review letters

Published: March 13, 2026

Impact of ASTCT Toxicity Grading System on Outcomes After CAR-T for Mature B-Cell Malignancies.

Impact of ASTCT Toxicity Grading System on Outcomes After CAR-T for Mature B-Cell Malignancies.

Journal: Transplantation and cellular therapy

Published: March 04, 2026

Impact of ASTCT toxicity grading system on outcomes after CAR-T for mature B-cell malignancies.

Impact of ASTCT toxicity grading system on outcomes after CAR-T for mature B-cell malignancies.

Journal: Transplantation and cellular therapy

Published: March 04, 2026

Showing 1-12 of 331

Last Updated: 09/26/2026